pyrrolidonecarboxylic acid has been researched along with Prostatic Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Guo, Z; Han, Z; He, J; Li, J; Li, Y; Liao, L; Luo, W; Luo, X; Shen, J; Xie, F; Zou, G | 1 |
| Cockle, SM; Hamilton, C; Malone, PR; Mundy, AR; Prater, GV; Thetford, CR | 1 |
| Block, NL; Gkonos, PJ; Kwok, CK; Roos, BA | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Prostatic Hyperplasia
| Article | Year |
|---|---|
Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.
Topics: Biomarkers; Humans; Male; Meglutol; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis; Pyrrolidonecarboxylic Acid | 2022 |
Peptides related to thyrotrophin-releasing hormone (TRH) in human prostate and semen.
Topics: Adult; Aged; Amino Acid Sequence; Animals; Biomarkers; Half-Life; Humans; Male; Molecular Sequence Data; Peptides; Prostate; Prostatic Hyperplasia; Pyrrolidonecarboxylic Acid; Rabbits; Radioimmunoassay; Semen; Thyrotropin-Releasing Hormone | 1994 |
Expression of prostatic TRH-like peptides differs between species and between malignant and nonmalignant tissues.
Topics: Animals; Chromatography, Ion Exchange; Hippocampus; Humans; Hypothalamus; Male; Oligopeptides; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Pyrrolidonecarboxylic Acid; Rabbits; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Species Specificity; Thyrotropin-Releasing Hormone | 1993 |